Abstract:Abstract Purpose Currently, the routine screening program has insufficient capacity for the early diagnosis of lung cancer. Therefore, a type of chitosan-molecular beacon (CS-MB) probe was developed to recognize the miR-155-5p and image the lung cancer cells for the early diagnosis. Methods Based on the molecular beacon (MB) technology and nanotechnology, the CS-MB probe was synthesized self-assembly. There are four types of cells—three kinds of animal models and one type of histopathological sections of human lung cancer were utilized as models, including A549, SPC-A1, H446 lung cancer cells, tumor-initiating cells (TICs), subcutaneous and lung xenografts mice, and lox-stop-lox(LSL) K-ras G12D transgenic mice. The transgenic mice dynamically displayed the process from normal lung tissues to atypical hyperplasia, adenoma, carcinoma in situ, and adenocarcinoma. The different miR-155-5p expression levels in these cells and models were measured by quantitative real-time polymerase chain reaction (qRT-PCR). The CS-MB probe was used to recognize the miR-155-5p and image the lung cancer cells by confocal microscopy in vitro and by living imaging system in vivo. Results The CS-MB probe could be used to recognize the miR-155-5p and image the lung cancer cells significantly in these cells and models. The fluorescence intensity trends detected by the CS-MB probe were similar to the expression levels trends of miR-155 tested by qRT-PCR. Moreover, the fluorescence intensity showed an increasing trend with the tumor progression in the transgenic mice model, and the occurrence and development of lung cancer were dynamically monitored by the differen fluorescence intensity. In addition, the miR-155-5p in human lung cancer tissues could be detected by the miR-155-5p MB. Conclusion Both in vivo and in vitro experiments demonstrated that the CS-MB probe could be utilized to recognize the miR-155-5p and image the lung cancer cells. It provided a novel experimental and theoretical basis for the early diagnosis of the disease. Also, the histopathological sections of human lung cancer research laid the foundation for subsequent preclinical studies. In addition, different MBs could be designed to detect other miRNAs for the early diagnosis of other tumors.

Novel molecular beacons to monitor microRNAs in non-small-cell lung cancer.

Monitoring microRNAs using a molecular beacon in CD133+/ CD338+ human lung adenocarcinoma-initiating A549 cells.

Detection of miR-155-5p and imaging lung cancer for early diagnosis: in vitro and in vivo study

Hairpin allosteric molecular beacons-based cascaded amplification for effective detection of lung cancer-associated microRNA

Detecting mir-155-3p through a Molecular Beacon Bead-Based Assay

Evaluation of miR-155 silencing using a molecular beacon in human lung adenocarcinoma cell line

Chitosan Combined With Molecular Beacon For Mir-155 Detection And Imaging In Lung Cancer

Identification and Imaging of Mir-155 in the Early Screening of Lung Cancer by Targeted Delivery of Octreotide-Conjugated Chitosan-Molecular Beacon Nanoparticles.

Tissue Micrornas in Non-Small Cell Lung Cancer Detected with a New Kind of Liquid Bead Array Detection System

Identification of miRNA Biomarkers for Non-small Cell Lung Cancer using Microarray Datasets and Bioinformatics Analysis

Ultrasensitive miRNA detection: A novel DNA nanomachine using split-type molecular beacons-mediated cascade amplification for cancer diagnostics

Molecular Beacon Nano-Sensors for Probing Living Cancer Cells

Molecular Beacon Nano-Sensors for Probing Living Cancer Cells.

MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer

Highly sensitive fluorescence multiplexed miRNAs biosensors for accurate clinically diagnosis lung cancer disease using LNA-modified DNA probe and DSN enzyme

Identification of Serum Mirnas by Nano-Quantum Dots Microarray As Diagnostic Biomarkers for Early Detection of Non-Small Cell Lung Cancer

Mirnas As Biomarkers and for the Early Detection of Non-Small Cell Lung Cancer (NSCLC)

A Novel Biosensor for the Ultrasensitive Detection of the Lncrna Biomarker MALAT1 in Non-Small Cell Lung Cancer

Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients

Quantitative Detection of Mirna-21 Expression in Tumor Cells and Tissues Based on Molecular Beacon.

A novel quantification platform for point-of-care testing of circulating MicroRNAs based on allosteric spherical nanoprobe